Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Clín. investig. arterioscler. (Ed. impr.) ; 35(5): 248-261, sep.-oct. 2023. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-226513

RESUMO

Para el tratamiento de la hipercolesterolemia, además de aconsejar una alimentación saludable, puede ser conveniente recomendar alimentos funcionales o nutracéuticos con efecto hipolipemiante. Dado el progresivo incremento en el número de estos productos y su creciente utilización por la población, la Sociedad Española de Arteriosclerosis (SEA) ha creído conveniente revisar la información disponible, seleccionar los resultados de los estudios científicamente más sólidos y posicionarse sobre la utilidad de los mismos, para recomendar a los profesionales sanitarios y a la población general su potencial utilidad en términos de eficacia y sus posibles beneficios y limitaciones. Se han identificado los siguientes escenarios clínicos en los que se podrían utilizar estos productos y que se analizarán con más detalle en este documento: 1. Tratamiento hipolipemiante en sujetos con intolerancia a estatinas. 2. Tratamiento hipolipemiante «a la carta» en personas en prevención primaria. 3. Prevención cardiovascular a largo plazo en personas sin indicación de tratamiento hipolipemiante. 4. Pacientes con tratamiento hipolipemiante optimizado que no alcanzan objetivos terapéuticos. (AU)


In the management of hypercholesterolemia, besides advising a healthy, plant-based diet, it may be useful to recommend functional foods or nutraceutical with cholesterol-lowering properties. Given the progressive increase in the number of these products and their rising use by the population, the Spanish Society of Arteriosclerosis (SEA) has considered it appropriate to review the available information, select the results of the scientifically more robust studies and take a position on their usefulness, to recommend to health professionals and the general population their potential utility in terms of efficacy and their possible benefits and limitations. The following clinical scenarios have been identified in which these products could be used and will be analyzed in more detail in this document: (1) Hypolipidemic treatment in subjects with statin intolerance. (2) Hypolipidemic treatment «a la carte» in individuals in primary prevention. (3) Long-term cardiovascular prevention in individuals with no indication for lipid-lowering therapy. (4) Patients with optimized lipid-lowering treatment who do not achieve therapeutic objectives. (AU)


Assuntos
Hipercolesterolemia/terapia , Suplementos Nutricionais , Alimento Funcional , Fitosteróis/administração & dosagem , Fitosteróis/uso terapêutico , Oryza , LDL-Colesterol
2.
Clin Investig Arterioscler ; 35(5): 248-261, 2023.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-36932013

RESUMO

In the management of hypercholesterolemia, besides advising a healthy, plant-based diet, it may be useful to recommend functional foods or nutraceutical with cholesterol-lowering properties. Given the progressive increase in the number of these products and their rising use by the population, the Spanish Society of Arteriosclerosis (SEA) has considered it appropriate to review the available information, select the results of the scientifically more robust studies and take a position on their usefulness, to recommend to health professionals and the general population their potential utility in terms of efficacy and their possible benefits and limitations. The following clinical scenarios have been identified in which these products could be used and will be analyzed in more detail in this document: (1) Hypolipidemic treatment in subjects with statin intolerance. (2) Hypolipidemic treatment «a la carte¼ in individuals in primary prevention. (3) Long-term cardiovascular prevention in individuals with no indication for lipid-lowering therapy. (4) Patients with optimized lipid-lowering treatment who do not achieve therapeutic objectives.


Assuntos
Anticolesterolemiantes , Arteriosclerose , Hipercolesterolemia , Humanos , Anticolesterolemiantes/uso terapêutico , Arteriosclerose/prevenção & controle , Colesterol , Suplementos Nutricionais , Alimento Funcional , Hipercolesterolemia/tratamento farmacológico
3.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) ; 48(6): 403-410, sept, 2022. ilus, tab
Artigo em Inglês | IBECS | ID: ibc-211025

RESUMO

Objective The use of nutritional supplements to treat hypercholesterolemia is gradually increasing, however further studies on their efficacy and safety are required. Patients and methods The present clinical trial included patients with moderate hypercholesterolemia and cardiovascular risk who were treated either with a nutraceutical preparation containing 3.75mg of monacolin K, 515mg of berberine and 50mg of coenzyme Q10 per tablet (Lipok®) or with a placebo. The clinical and laboratory variables were analyzed at baseline and at three and six months. None of the patients was diabetic, and none was being treated with lipid-lowering drugs or with any other nutritional supplements affecting lipid metabolism. Results In patients of the intervention group and of the placebo group, baseline LDL-C was 134.7mg/dL (14.4) and 138.7mg/dL (15.2), respectively. At three months after treatment start, LDL-C had decreased by 26.1mg/dL (−32.4 to 19.7) and increased by 4.5mg/dL (−1.5 to 10.5) in the respective groups. In the intervention group, a similar decrease in non-HDL-C and total cholesterol was observed, while no significant changes were observed in either group for HDL-C, triglycerides and lipoprotein(a). A good tolerance and safety profile was observed. Conclusion In conclusion, this study demonstrates that the combination of monacolin K, berberine and coenzyme Q10 is effective and safe for treating hypercholesterolemia in patients with a moderate degree of excess LDL-C and cardiovascular risk (AU)


Objetivo El uso de suplementos nutricionales para tratar la hipercolesterolemia está aumentando de forma progresiva; sin embargo son necesarios más estudios sobre su eficacia y seguridad. Pacientes y métodos En el presente ensayo clínico fueron incluidos pacientes con hipercolesterolemia y riesgo cardiovascular moderados que fueron tratados con un preparado nutracéutico que contenía 3,75mg de monacolina K, 515mg de berberina y 50mg de coenzima Q10 por comprimido (Lipok®) o con placebo. Se analizaron las variables clínicas y de laboratorio en situación basal y a los 3 y 6 meses. Ningún paciente era diabético y ninguno seguía tratamiento con fármacos hipolipidemiantes u otros suplementos nutricionales con efectos sobre el metabolismo lipídico. Resultados En los pacientes del grupo de intervención y del grupo placebo, el c-LDL basal era de 134,7mg/dL (14,4) y 138,7mg/dL (15,2), respectivamente. A los 3 meses de tratamiento el c-LDL había disminuido 26,1mg/dL (de –32,4 a 19,7) y aumentado 4,5mg/dL (de –1,5 a 10,5) en ambos grupos, respectivamente. En el grupo de intervención se observó un descenso similar del c-no HDL y del colesterol total, mientras que no ocurrieron cambios significativos en ninguno de los 2 grupos en el c-HDL, los triglicéridos y la lipoproteína (a). Se observó un buen perfil de tolerancia y seguridad. Conclusión Este estudio demuestra que la combinación de monacolina K, berberina y coenzima Q10 es eficaz y segura para tratar la hipercolesterolemia en los pacientes con un grado de exceso de c-LDL y de riesgo cardiovascular moderados (AU)


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Doenças Cardiovasculares/etiologia , Suplementos Nutricionais , Berberina/uso terapêutico , LDL-Colesterol/sangue , Fatores de Risco , Metabolismo dos Lipídeos , Lovastatina/uso terapêutico , Resultado do Tratamento , Estudos Prospectivos
4.
Semina cienc. biol. saude ; 43(2): 295-304, jul./dez. 2022. ilus
Artigo em Português | LILACS | ID: biblio-1426506

RESUMO

O papel dos produtos naturais, em especial os nutracêuticos, vem ganhando destaque nos últimos anos devido aos efeitos positivos em parâmetros relacionados à saúde. O açafrão é uma espécie originária do sudeste da Ásia e considerado uma preciosa especiaria. Além da principal utilização como condimento, possui substâncias com atividades antioxidante, antimicrobiana e corante, que lhe conferem possibilidade de emprego nas áreas de cosméticos, têxtil e alimentícia, sendo também muito utilizado nas medicinas tradicionais chinesa e indiana. Seu principal composto fenólico, a curcumina, tem sido amplamente estudado, por apresentar uma variedade de propriedades para a saúde, como efeitos antioxidantes, anti-inflamatórios, antivirais, antibacterianos, antidepressivos e anticancerígenos e, assim, potencial de ação contra várias doenças crônicas. Portanto, o objetivo do presente estudo foi revisar os efeitos do açafrão nos parâmetros biológicos e comportamentais, bem como sua utilização na manutenção da saúde e qualidade de vida dos indivíduos.


The role of natural products, especially nutraceuticals, has been gaining prominence in recent years due to their positive effects on health-related parameters. Turmeric is a species native to Southeast Asia and considered a precious spice. In addition to its main use as a condiment, it has substances with antioxidant, antimicrobial, and coloring activity, which give it the possibility of being used in the areas of cosmetics, textiles, and food; It is also widely used in traditional Chinese and Indian medicine. Its main phenolic compound, curcumin, has been widely studied, as it has a variety of health properties, such as antioxidant, anti-inflammatory, antiviral, antibacterial, antidepressant and anticancer effects and, thus, potential for action against various chronic diseases. Therefore, the objective of the present study was to review the effects of saffron on biological and behavioral parameters, as well as its use in maintaining the health and quality of life of individuals.


Assuntos
Humanos , Antivirais , Saúde , Anticarcinógenos , Anti-Inflamatórios , Antibacterianos , Antidepressivos , Antioxidantes
5.
Semergen ; 48(6): 403-410, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35606250

RESUMO

OBJECTIVE: The use of nutritional supplements to treat hypercholesterolemia is gradually increasing, however further studies on their efficacy and safety are required. PATIENTS AND METHODS: The present clinical trial included patients with moderate hypercholesterolemia and cardiovascular risk who were treated either with a nutraceutical preparation containing 3.75mg of monacolin K, 515mg of berberine and 50mg of coenzyme Q10 per tablet (Lipok®) or with a placebo. The clinical and laboratory variables were analyzed at baseline and at three and six months. None of the patients was diabetic, and none was being treated with lipid-lowering drugs or with any other nutritional supplements affecting lipid metabolism. RESULTS: In patients of the intervention group and of the placebo group, baseline LDL-C was 134.7mg/dL (14.4) and 138.7mg/dL (15.2), respectively. At three months after treatment start, LDL-C had decreased by 26.1mg/dL (-32.4 to 19.7) and increased by 4.5mg/dL (-1.5 to 10.5) in the respective groups. In the intervention group, a similar decrease in non-HDL-C and total cholesterol was observed, while no significant changes were observed in either group for HDL-C, triglycerides and lipoprotein(a). A good tolerance and safety profile was observed. CONCLUSION: In conclusion, this study demonstrates that the combination of monacolin K, berberine and coenzyme Q10 is effective and safe for treating hypercholesterolemia in patients with a moderate degree of excess LDL-C and cardiovascular risk.


Assuntos
Berberina , Doenças Cardiovasculares , Hipercolesterolemia , Berberina/efeitos adversos , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/prevenção & controle , LDL-Colesterol , Suplementos Nutricionais/efeitos adversos , Fatores de Risco de Doenças Cardíacas , Humanos , Hipercolesterolemia/tratamento farmacológico , Metabolismo dos Lipídeos , Lovastatina/farmacologia , Lovastatina/uso terapêutico , Fatores de Risco , Resultado do Tratamento , Ubiquinona/análogos & derivados
6.
Perspect. nutr. hum ; 23(2): 199-220, jul.-dic. 2021. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1375987

RESUMO

Resumen Antecedentes: los tratamientos con base en medicamentos contra la COVID-19 no han sido aprobados hasta la actualidad. La forma más efectiva de enfrentar este problema de salud pública es la prevención con una adecuada alimentación, medidas de higiene y protección. Los alimentos han sido históricamente utilizados por la población para mejorar su nutrición y complementar el tratamiento o prevención de enfermedades. Se conocen los diversos compuestos bioactivos de algunos alimentos, que en estudios experimentales demostraron su acción antiviral e inmunomoduladora. Objetivo: identificar los compuestos bioactivos o preparados de alimentos con potencial efecto inmunomodulador, inmunoestimulante y antiviral contra el coronavirus. Materiales y métodos: se realizó una búsqueda en Google Scholar, Scopus y en la Biblioteca Virtual de Salud en Bases de datos de Medicina Tradicional, Complementaria e Integrativa utilizando los términos food, immunomodulatory, immunostimulatory y antiviral en cuatro búsquedas sucesivas. Resultados: se obtuvieron 93 artículos y se identificó mayor evidencia sobre el efecto antiviral e inmunológico contra el coronavirus en nueve alimentos: Allium sativum, Cinnamomum zeylanicum, Citrus sinensis, Zingiber officinale, Vitis vinífera, Allium cepa, Curcuma longa, Punica granatum y Sambucus nigra. Los cuatro primeros mostraron actividad contra el SARS-CoV-2. Conclusiones: se evidenció el efecto inmunológico y antiviral contra el coronavirus de nueve alimentos; sin embargo, son estudios in silico e in vitro, por ello se requiere mayor investigación preclínica y clínica que lo confirmen.


Abstract Background: Up to date drug-based treatments for COVID-19 have not been approved. The most effective way to face this public health problem is prevention with adequate nutrition, hygiene, and protection measures. Food has historically been used by people to improve their nutrition and complement the treatment or prevention of diseases. The various bioactive compounds of some foods are known, which in experimental studies demonstrated their antiviral and immunomodulatory action. Objective: To identify bioactive compounds of foods or food preparations with potential immunomodulatory, immunostimulatory, and antiviral effects against coronavirus. Material and Methods: A search was carried out in Google Scholar, Scopus, and Virtual Health Library on Traditional Complementary and Integrative Medicine using the terms food, immunomodulatory, immunostimulatory, and antiviral in four successive searches. Results: 93 articles were obtained, and further evidence of antiviral and immunological effect against coronavirus was identified on nine foods: Allium sativum, Cinnamomum zeylanicum, Citrus sinensis, Zingiber officinale, Vitis vinifera, Allium cepa, Curcuma longa, Punica granatum, and Sambucus nigra. The first four of them showed activity against SARS-CoV-2. Conclusions: The immunological and antiviral effect against coronavirus of nine foods was evidenced; however, they are in silico and in vitro studies, therefore it is required further preclinical and clinical research to confirm this.


Assuntos
Antivirais , Coronavirus
7.
Acta biol. colomb ; 26(1): 89-98, ene.-abr. 2021. tab, graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1152672

RESUMO

RESUMEN Pleurotus sp. es un género de basidiomicetos ampliamente distribuido a nivel mundial, con especies que revisten importancia, no solo desde el punto de vista comercial por su valor nutricional, sino también por sus propiedades medicinales. Sin embargo, aún son insuficientes los estudios micoquímicos y se desconoce su relación con las propiedades antioxidantes de bioproductos obtenidos de estas setas durante diferentes estados de crecimiento. En el presente trabajo, se determinó el contenido de proteínas, carbohidratos, azúcares reductores, fenoles totales y flavonoides, así como la actividad antioxidante in vitro (ensayos de captación de radicales DPPH y estimación del poder reductor) de extractos acuosos de Pleurotus ostreatus en dos estados de crecimiento (primordios y cuerpos fructíferos maduros) durante la fermentación sólida. El contenido de proteínas, azúcares reductores y flavonoides fue superior en el extracto acuoso de cuerpos fructíferos maduros, mientras que los carbohidratos y fenoles totales fueron mayores en el extracto de primordios. Los valores de EC50 en los ensayos de DPPH y los de poder reductor fueron de 1,72 mg/mL y 3,27 mg/mL para el extracto de primordios y de 0,44 mg/mL y 0,48 mg/mL para el de cuerpos fructíferos maduros, respectivamente. Los resultados sugieren que las propiedades antioxidantes de extractos acuosos de Pleurotus ostreatus (primordios y cuerpos fructíferos maduros) reflejan las variaciones en la concentración de moléculas bioactivas, teniendo en cuenta las particularidades fisiológicas de las fases de crecimiento. Ello podría resultar de utilidad para el diseño de protocolos de obtención de bioproductos de Pleurotus ostreatus con aplicaciones potenciales como antioxidantes en las industrias alimentaria y farmacéutica.


ABSTRACT Pleurotus sp. is a genus of Basidiomycetes widely distributed worldwide, with species that are important not only from the commercial point of view for its nutritional value, but also for their medicinal properties. However, mycochemical studies and the relationship with the antioxidant properties of bioproducts obtained from these mushrooms during different growth stages are still insufficient. In this work, the content of proteins, carbohydrates, reducing sugars, total phenols and flavonoids was determined, as well as the in vitro antioxidant activity (tests of scavenging DPPH and reducing power estimation) of aqueous extracts of Pleurotus ostreatus in different growth stages (primordia and mature fruiting bodies) during the solid fermentation. The content of proteins, reducing sugars and flavonoids was higher in the aqueous extract ofmature fruiting bodies, while carbohydrates and total phenols were increased in the extract ofprimordia. The EC50 values in the DPPH and reducing power assays were 1.72 mg/mL and 3.27 mg/mL for primordia extract and 0.44 mg/mL and 0.48 mg/mL in the case of mature fruiting bodies extract, respectively. The results suggest that the antioxidant properties of Pleurotus ostreatus aqueous extracts (primordia and mature fruiting bodies), reflected the variations in the concentration of bioactive molecules, taking into account the physiological characteristics of the growth phases. This could be useful in designing protocols for obtaining bioproducts from Pleurotus ostreatus with potential applications as antioxidant in food and pharmaceutical industries.

8.
Rev. bras. neurol ; 57(1): 30-38, jan.-mar. 2021. tab
Artigo em Português | LILACS | ID: biblio-1177699

RESUMO

OBJETIVO: Pesquisar as recomendações nutricionais para pacientes com Distrofia Muscular de Duchenne (DMD). MÉTODO: Trata- se de uma revisão integrativa da literatura, através de levantamento bibliográfico nas bases cientificas PubMed e Scielo, foram utilizadas as palavras chaves: Distrofia Muscular de Duchenne em combinação com os termos Nutrição, Nutrientes, Nutracêuticos, Vitaminas e Antioxidantes. Foi realizada a busca dos artigos publicados nos últimos 10 anos. RESULTADOS: Foram selecionados 102 artigos, dos quais após análise dos critérios de exclusão e inclusão, resultaram em 31 artigos referentes a 31,62% da amostra inicial que foram utilizados para a produção dessa revisão. CONCLUSÃO: O acompanhamento nutricional do paciente com DMD é fundamental, de forma a garantir a manutenção do estado nutricional, além de contribuir de forma significativa para a desaceleração dos sintomas da doença e melhora da qualidade de vida.


OBJECTIVE: To search for nutritional recommendations for patients with Duchenne Muscular Dystrophy (DMD). METHOD: It is an integrative review of the literature, through a bibliographic survey on the scientific bases PubMed and Scielo, the keywords used were Duchenne Muscular Dystrophy in combination with the terms Nutrition, Nutrients, Nutraceuticals, Vitamins and Antioxidants. The search was based on articles published in the last 10 years. RESULTS: A total of 102 articles were selected, of which, after analyzing the exclusion and inclusion criteria, resulted in 32 articles referring to 32.64% of the initial sample that were used to produce this review. CONCLUSION: Nutritional monitoring of patients with DMD is essential, in order to guarantee the maintenance of nutritional status, in addition to contributing significantly to the deceleration of the symptoms of the disease and improving the quality of life.


Assuntos
Humanos , Masculino , Pré-Escolar , Criança , Adolescente , Vitaminas/administração & dosagem , Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/dietoterapia , Terapia Nutricional/métodos , Recomendações Nutricionais , Estado Nutricional , Antioxidantes
9.
Arq. neuropsiquiatr ; 78(8): 501-511, Aug. 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1131741

RESUMO

ABSTRACT Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive and irreversible loss of cognitive function. The presence of senile plaques is one of the pathological markers of the disease and is associated with the onset of neuroinflammatory mechanisms. The exact pathophysiology of AD has not been completely understood, and there are no curative therapies yet. Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol that is noted for its antioxidant and anti-inflammatory properties. Objective: To review the role of resveratrol in the pathophysiological aspects of AD. Methods: This study carried out a literature review using PubMed/Medline, Virtual Health Library (VHL), Web of Sciences, SCOPUS and the Cochrane Library databases. Original research articles, describing both in vitro and in vivo experiments, published between 2008 and 2018, were included. Results: We identified 667 articles, of which 619 were excluded because they were repeated or did not follow the inclusion criteria. The present study includes the remaining 48 articles. Discussion: Resveratrol demonstrates beneficial and protective effects in AD models and seems to provide a promising therapeutic alternative. Conclusion: Although resveratrol appears to mitigate some pathophysiological aspects of AD, further studies are needed to prove the safety and efficacy of this compound in humans.


RESUMO Introdução: A doença de Alzheimer (DA) é neurodegenerativa e caracterizada por perda progressiva e irreversível da função cognitiva. A presença de placas senis é um dos marcadores patológicos da doença e está associada ao aparecimento de mecanismos neuroinflamatórios. A fisiopatologia exata da DA ainda não é completamente compreendida, e ainda não existem terapias curativas. O resveratrol (3,5,4'-trihidroxi-trans-estilbeno) é um polifenol conhecido por suas propriedades antioxidantes e anti-inflamatórias. Objetivo: Revisar o papel do resveratrol nos aspectos fisiopatológicos da DA. Métodos: Este estudo realizou uma revisão narrativa da literatura a partir das bases de dados PubMed/Medline, Biblioteca Virtual em Saúde (BVS), Web of Science, SCOPUS e Cochrane Library. Foram incluídos artigos originais, realizados in vitro e in vivo, publicados entre 2008 e 2018. Resultados: Foram identificados 667 artigos, dos quais 619 foram excluídos por estarem repetidos ou não se enquadrarem nos critérios de inclusão. O presente estudo inclui os 48 artigos restantes. Discussão: O resveratrol demonstra efeitos benéficos e protetores em modelos de DA, bem como parece fornecer uma alternativa terapêutica promissora. Conclusão: Embora o resveratrol pareça atenuar alguns aspectos fisiopatológicos da DA, são necessários mais estudos para comprovar a segurança e a eficácia deste composto em seres humanos.


Assuntos
Humanos , Doença de Alzheimer/tratamento farmacológico , Cognição , Resveratrol/uso terapêutico , Antioxidantes
10.
Rev. salud pública ; 22(3): e287216, May-June 2020.
Artigo em Espanhol | LILACS | ID: biblio-1127228

RESUMO

RESUMEN Hace unos cuantos siglos, en la materia médica de los nahuas prehispánicos se incluían alimentos curativos. En la actualidad, legitimado por las ciencias experimentales, nace el nutracéutico como un alimento con propiedades curativas que se utiliza en los modelos de salud preventivos del cáncer. En este artículo, comienzo por proponer que el conocimiento prehispánico puede ser validado epistémica y metodológicamente, si se apela al particular marco conceptual de los prehispánicos. Después, arguyo que el consumo de nutracéticos, como anticancerígenos, puede pensarse como parte de medidas preventivas primarias y secundarias, así como en la comprensión de las prácticas de autocuidado en el marco de la ética contemporánea del cáncer. Concretamente, que el consumo de nutracéticos y los alimentos prehispánicos mexicanos pueden legitimarse como prácticas de bienestar y prevención cada vez más pertinentes, en la intersección de la experiencia del enfermo y de su contexto. La responsabilidad de quien padece, dentro de un contexto sociopolítico cada vez más estructurado por las exigencias de vulnerabilidad del mercado terapéutico y de las estrategias confesionarias que otorgan verdad y validez a las figuras de autoridad, se gana en la práctica de conocerse y entenderse a sí mismo en la intersubjetividad contextual.(AU)


ABSTRACT The pre-Hispanic Nahuas had a medical system that included healing foods among their therapeutic practices. Nowadays, a new knowledge is born, legitimated by experimental sciences: the nutraceutical, a food with curative properties used in cancer preventive health models. In this article, I begin by proposing that pre-Hispanic knowledge can be validated epistemically and methodologically, if we appeal to the particular conceptual framework of the pre-Hispanic. Later, that the consumption of nutraceuticals, as anti-cancer drugs, can be thought of as part of primary and secondary preventive measures, as well as in the understanding of self-care practices in the framework of contemporary cancer bioethics. Specifically, that the consumption of nutraceuticals and Mexican pre-Hispanic foods can be legitimized as increasingly relevant wellness and prevention practices, at the intersection of the patient's experience and his or her context. The responsibility of those who suffer, within a sociopolitical context that is increasingly structured by the demands of vulnerability of the therapeutic market and the confessional strategies that give truth and validity to the figures of authority over whom they suffer, is gained in the practice of knowing and understanding oneself within contextual intersubjetivity.(AU)


Assuntos
Humanos , Biotecnologia/tendências , Materia Medica , Suplementos Nutricionais , Suplementos Nutricionais/provisão & distribuição , Licopeno/uso terapêutico , Neoplasias/prevenção & controle
11.
Preprint em Inglês | SciELO Preprints | ID: pps-317

RESUMO

The present prospective work of scientific articles related to foods and natural products with anti-Covid activity in databases in order to present a scientific community, to governments and society as main foods, nutraceuticals and medicinal plants as strategies used by countries during the COVID-19 pandemic. A review of articles on food, medicinal plants and biotechnology was carried out in databases of scientific articles such as: CAPES journals, PubMed, Elsevier's Science Direct, Willey on library library, Taylor & Francis Springer-Nature database, BMC, Hindawi, Scielo, ACS - American Chemical Society, Google Scholar, in addition to the Patent Database "The LENS" and "Questel-Orbit". Foods used in daily life such as garlic, ginger, turmeric, sour orange, vegetables, lactobacilli demonstrate proven anti-virus action. Medicinal plants used by Traditional Chinese, Korean and Indian Medicine also demonstrate anti-Covid activity and used during the coronavirus outbreak. Some medicinal plants, green propolis extract, red propolis extract, royal gelly, polen, honey have also been cited as anti-covid, natural anti-inflammatory and immunomodulatory products.


O presente trabalho prospectou artigos científicos relacionadas à alimentos e produtos naturais com atividade anti-Covid com o intuito de apresentar, à comunidade científica, aos governos e à sociedade, dados sobre as principais estratégias nutracêuticas, biotecnológicas e plantas medicinais utilizadas em alguns países durante o enfrentamento da pandemia COVID-19. A revisão de artigos sobre alimentos, plantas medicinais e produtos biotecnológicos foi realizada nas bases de dados periódicos da CAPES, PubMed, Science Direct, Willey on line library, Springer-Nature, Taylor & Francis, BMC, Hindawi, Scielo, ACS ­ American Chemical Society, Google acadêmico, "The LENS" e Questel-Orbit. Alimentos de uso frequente como alho, gengibre, cúrcuma, laranja azeda, vegetais e lactobacilos demonstraram ação anti-coronavirus comprovada. Foram descritos usos de plantas medicinais da Medicina tradicional Chinesa, Coreana, Indiana bastante utilizadas durante a pandemia. Algumas plantas medicinais e nutracêuticos como: extrato de própolis verde e extrato de própolis vermelha brasileiras, geleia real, pólen e mel também foram citados como produtos anti-covid, antiinflamatórios naturais e imunomodulatórios.

12.
Hig. aliment ; 34(290): 1-9, Janeiro/Junho 2020. tab
Artigo em Português | LILACS, VETINDEX | ID: biblio-1482529

RESUMO

O objetivo desse estudo foi avaliar a atividade antimicrobiana e antioxidante de polpa e casca do fruto de uxi. As amostras foram coletadas na cidade de Parintins - AM. Ao pesquisar a atividade antimicrobiana, as concentrações estudadas não apresentaram inibição do desenvolvimento microbiano, assim como para a atividade antioxidante, onde através dos extratos em DMSO, não houve inibição satisfatória do radical livre pelos métodos DPPH, ABTS e para compostos fenólicos totais. O estudo servirá como base para refinamentos direcionados ao estudo dessa temática.


The aim of this study was to evaluate the antimicrobial and antioxidant activity of uxi fruit pulp and rind. The samples were collected in the city of Parintins - AM. When investigating the antimicrobial activity, the studied concentrations did not show inhibition of microbial development, as well as the antioxidant activity, where through DMSO extracts, there was no satisfactory inhibition of free radical by DPPH, ABTS methods and for total phenolic compounds. The study will serve as a basis for refinements directed to the study of this theme.


Assuntos
Anti-Infecciosos , Antioxidantes , Frutas
13.
Hig. Aliment. (Online) ; 34(290): 9, Janeiro/Junho 2020.
Artigo em Português, Inglês | LILACS-Express | LILACS | ID: biblio-1393417

RESUMO

O objetivo desse estudo foi avaliar a atividade antimicrobiana e antioxidante de polpa e casca do fruto de uxi. As amostras foram coletadas na cidade de Parintins - AM. Ao pesquisar a atividade antimicrobiana, as concentrações estudadas não apresentaram inibição do desenvolvimento microbiano, assim como para a atividade antioxidante, onde através dos extratos em DMSO, não houve inibição satisfatória do radical livre pelos métodos DPPH, ABTS e para compostos fenólicos totais. O estudo servirá como base para refinamentos direcionados ao estudo dessa temática


The aim of this study was to evaluate the antimicrobial and antioxidant activity of uxi fruit pulp and rind. The samples were collected in the city of Parintins - AM. When investigating the antimicrobial activity, the studied concentrations did not show inhibition of microbial development, as well as the antioxidant activity, where through DMSO extracts, there was no satisfactory inhibition of free radical by DPPH, ABTS methods and for total phenolic compounds. The study will serve as a basis for refinements directed to the study of this theme

14.
Rev. chil. reumatol ; 34(3): 122-127, 2018.
Artigo em Espanhol | LILACS | ID: biblio-1254233

RESUMO

El manejo del dolor articular ofrece para la población afectada novedosos suplementos nutricionales que incluyen el colágeno, y cuya extracción es desde variadas fuentes de origen animal, no así de vegetales. Esta revisión tiene como objetivo aclarar qué es el colágeno, su constitución estructural molecular, el rol que cumple en nues-tro organismo y revisar las indicaciones propuestas por la literatura, tanto para la profilaxis como el tratamiento de cuadros reumatológicos de alta prevalencia o impacto funcional, como son Artrosis, Artritis Reumatoidea y Osteoporosis.


Novel nutritional supplements for the management of joint pain have been made available to the population, including collagen, which can not be extracted from plant products, but from a variety of animal sources. This review aims to clarify what it is collagen, the molecular structures that constitute it, the determined role they play in our body and review the indications that the literature proposes both in prophylaxis and treatment, for high prevalence rheumatologic or functional impact, such as osteoarthritis, rheumatoid arthritis and osteoporosis.


Assuntos
Humanos , Doenças Reumáticas/terapia , Colágeno/uso terapêutico , Osteoartrite/terapia , Osteoporose/terapia , Artrite Reumatoide/terapia , Matriz Extracelular
15.
Conscientiae saúde (Impr.) ; 16(2): 2017217223, jun. 2017.
Artigo em Português | LILACS | ID: biblio-875793

RESUMO

Introdução: A hipertensão arterial é um dos fatores de risco para doenças cardiovasculares, estando diretamente associada ao elevado consumo de sódio. Objetivo: Avaliar os níveis de marcadores de lesão hepática, renal e cardíaca em ratos hipertensos comparados aos seus controles normotensos, tratados com um salgante isento de sódio, água ou NaCl. Métodos: Ratos hipertensos (SHR) e seus controles normotensos (NWR) foram divididos em 3 grupos (n=7): G1 (água); G2 (solução aquosa contendo NaCl 70 mg/kg/dia); G3 (solução aquosa contendo salgante sem sódio 70 mg/kg/dia). Após 30 dias, o sangue dos animais foi processado. Resultados: Não houve diferença entre os níveis séricos de creatina quinase total, creatina quinase-MB, lactato desidrogenase, ácido úrico, aspartato aminotransferase e fosfatase alcalina tanto nos NWR como nos SHR tratados com NaCl ou Salgante. Houve diminuição da creatinina nos NWR e SHR tratados com NaCl e Salgante em relação aos controles (p<0,005). Conclusões: A suplementação diária com o Salgante e NaCl diminuiu os níveis séricos de creatinina nos grupos NWR e SHR. Contudo, não houve modificação nos níveis séricos de marcadores de lesão cardíaca e hepática. (AU)


Introduction: Hypertension is one of the risk factors for cardiovascular diseases, being directly associated with high consumption of sodium. Objective: To assess the levels of hepatic, renal and cardiac injury markers in hypertensive rats compared to their normotensive controls, treated with a salt free saline solution, water or NaCl. Methods: Hypertensive rats (SHR) and their normotensive controls (NWR) were divided into 3 groups (n = 7): G1 (water); G2 (aqueous solution containing NaCl 70 mg / kg / day); G3 (sodium salt-free aqueous solution 70 mg / kg / day). After 30 days, the animals' blood was processed. Results: There was no difference between serum levels of total creatine kinase, creatine kinase-MB, lactate dehydrogenase, uric acid, aspartate aminotransferase and alkaline phosphatase in both NWR and SHR1 treated NaCl or Salgante. There was a decrease in creatinine in NWR and SHR treated with NaCl and Salgante comparing to controls (p <0.005). Conclusions: Daily supplementation with sodium salt-free aqueous solution and NaCl decreases serum creatinine levels in NWR and SHR groups. However, there was no change in serum levels of cardiac and hepatic injury markers. (AU)


Assuntos
Animais , Masculino , Ratos , Cloreto de Sódio na Dieta , Aspartato Aminotransferases/sangue , Ácido Úrico/sangue , Biomarcadores , Ratos Wistar , Suplementos Nutricionais , Creatina Quinase/sangue , Fosfatase Alcalina/sangue , Frequência Cardíaca , L-Lactato Desidrogenase/sangue
16.
J Optom ; 10(1): 26-33, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27425263

RESUMO

PURPOSE: To determine the combined effect of TheraTears® Lubricant Eye Drops, TheraTears® SteriLid Eyelid Cleanser, and TheraTears® Nutrition on dry eye signs and symptoms. METHODS: This prospective study enrolled 28 dry eye participants. Participants were instructed to use the Lubricant Eye Drops at least 2-4× a day, SteriLid 1-2× a day, and Nutrition 3 gel caps once a day. Participants were followed up at baseline, 1 month and 3 months. Outcome variables were the Ocular Surface Disease Index (OSDI), Symptom Assessment iN Dry Eye (SANDE) questionnaire, non-invasive tear break-up time (NIBUT), osmolarity, number of meibomian glands blocked (#MG blocked), meibum quality, eyelid margin features, Schirmer's test, tear film lipid layer thickness (LLT), meniscus height, corneal and conjunctival staining. RESULTS: Twenty participants (mean age=43, from 23 to 66, 17F, 3M) completed the study. Participants reported having used, on average, the Lubricant Eye Drop 2.4×/day, the SteriLid 1.1×/day, and the Nutrition 3 gel caps 1×/day. There was a significant change over time (p<0.05) for OSDI (-21.2 points), SANDE (-32.4 points), NIBUT (+0.43s), eyelid margin features (-1.1 grade), meibum quality (-1.0 grade), and #MG blocked (-4.0 glands). CONCLUSION: By using a combination of TheraTears® Lubricant Eye Drop, SteriLid, and Nutrition, patients experience significant relief in both dry eye symptoms and signs.


Assuntos
Suplementos Nutricionais , Síndromes do Olho Seco/terapia , Higiene , Lubrificantes Oftálmicos/uso terapêutico , Soluções Oftálmicas/uso terapêutico , Adulto , Idoso , Análise de Variância , Túnica Conjuntiva/patologia , Córnea/patologia , Síndromes do Olho Seco/metabolismo , Síndromes do Olho Seco/patologia , Feminino , Humanos , Masculino , Glândulas Tarsais/fisiopatologia , Pessoa de Meia-Idade , Estudos Prospectivos , Inquéritos e Questionários , Lágrimas/metabolismo , Adulto Jovem
17.
Clin Investig Arterioscler ; 28(4): 178-87, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27131395

RESUMO

BACKGROUND AND AIM: A nutraceutical combination containing berberine, policosanol, and red yeast rice, largely marketed in Europe (Armolipid Plus(®)) (AP), has been reported to induce significant improvements in plasma lipids, insulin resistance and other components of the metabolic syndrome. However, literature study designs and results were heterogeneous and it was thus necessary to systematically review and meta-analyse all relevant randomised clinical trials (RCTs) to explore and quantify the effects of the dietary supplement AP on lipid profile. The aim of our meta-analysis was the evaluation of the effect of AP on lipid profile. METHODS AND RESULTS: We conducted a structures search on PubMed and Google Scholar to identify eligible articles published prior to 2015. Eleven RCTs were subjected to meta-analysis by means of random effects models using the Standardised Mean Differences approach (Hedges' method) and the Mean Differences approach as a sensitivity analysis. Data from 11 randomised clinical trials, corresponding to 1970 nutraceutical combination and 1954 control patients (3924 total patients), were included after the peer evaluation and data extraction of two independent evaluators. Heterogeneity was significant in all models. A significant effect was found for all lipid parameters. The effect size (relative change from baseline (%)) was -1.3 (9.9%) for total cholesterol, -1.17 (-13.7%) for LDL-c, +0.17 (+3.7%) for HDL-c and -0.24 (-7.0%) for Triglycerides. CONCLUSION: This meta-analysis confirms that the nutraceutical combination containing berberine, policosanol, and red yeast rice has shown to be an effective product for the improvement of the lipid profile.


Assuntos
Suplementos Nutricionais , Hipercolesterolemia/tratamento farmacológico , Lipídeos/sangue , Berberina/administração & dosagem , Berberina/farmacologia , Produtos Biológicos/administração & dosagem , Produtos Biológicos/farmacologia , Álcoois Graxos/administração & dosagem , Álcoois Graxos/farmacologia , Humanos , Hipercolesterolemia/sangue , Hipolipemiantes/administração & dosagem , Hipolipemiantes/farmacologia , Ensaios Clínicos Controlados Aleatórios como Assunto
18.
Braz. j. pharm. sci ; 51(3): 499-513, July-Sept. 2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-766322

RESUMO

Resveratrol (RSV), a natural polyphenol found in grapes, was found to be effective in the prevention and therapy of several diseases, however, it does have unfavourable physicochemical properties. In this context, an increasing number of studies have aimed at developing novel therapeutic systems for its delivery to overcome these disadvantages. This review focuses on the mechanisms of action and therapeutic applications. Finally, it also describes some tested formulations for RSV administration, controlled release and targeting, developed with the purpose of increasing RSV bioavailability.


O resveratrol (RSV) é um polifenol natural encontrado nas uvas, que se mostrou eficaz na prevenção e terapia de várias doenças. No entanto, apresenta propriedades físico-químicas desfavoráveis. Neste contexto, um número cada vez maior de estudos visando ao desenvolvimento de novos sistemas terapêuticos para a sua liberação vem sendo desenvolvido no sentido de ultrapassar estas desvantagens. Esta revisão discorre sobre os mecanismos de ação e aplicações terapêuticas do RSV. Finalmente, são abordadas algumas formulações de liberação controlada e vetorizada, testadas para administração do RSV, desenvolvidas com a finalidade de aumentar a biodisponibilidade do RSV.


Assuntos
Preparações Farmacêuticas/administração & dosagem , Polifenóis/análise , Sistemas de Liberação de Medicamentos/instrumentação , Vitis/classificação , Usos Terapêuticos
19.
Rev. chil. nutr ; 41(2): 198-204, June 2014. ilus, graf
Artigo em Espanhol | LILACS | ID: lil-722915

RESUMO

The increase of economic development and life expectancy of humans has aroused concerns about the health and nutrition in important groups of the population. These modifications have stimulated the development of functional foods (FF), nutraceuticals (NT) and FOSHU (Food with Specific Health Uses) in many countries around the world, mainly in those of greater development. FF are foods to which one or more healthy component has been added without changing its characteristics. The definition of FF is now incorporated into the food normative of many countries. NT is a more complex concept, because it is not referred to a food but to components of a food that can be ingested in amounts greater than those frequently consumed. NT are not pharmaceuticals since they have no therapeutic action although they may have preventive properties. FOSHU is a concept of foods with exclusive medical actions developed in Japan. This review discusses the significance of these new food concepts establishing their origins, potentialities, differences and future projections of these types of foods or food components.


El mayor desarrollo económico y las mayores expectativas de vida de la población, motivan una mayor preocupación por la salud y la alimentación a importantes grupos de la población. Estos cambios han motivado el desarrollo de los llamados alimentos funcionales (AF) y de los nutracéuticos (NT) y de los FOSHU (Food with Specific Health Uses) en varios países del mundo, principalmente en aquellos de mayor desarrollo económico. AF y NT son conceptos diferentes. Los AF son alimentos a los cuales se les ha incrementado o incorporado un componente cuyo consumo representa un beneficio de salud establecido, sin que el producto deje de ser un alimento. La definición de AF está ahora incorporada en la normativa alimentaria de varios países. NT es un concepto más complejo, ya que no se trata de alimentos pero sí de componentes de estos que se pueden consumir en mayores concentraciones que las habituales. Tampoco son medicamentos ya que no se les atribuye propiedades terapéuticas pero sí potencialmente preventivas. FOSHU es un concepto de alimentación con fines medicinales exclusivo de Japón. Este trabajo revisa el significado de estos nuevos conceptos alimentarios estableciendo sus orígenes, potencialidades, diferencias y las futuras proyecciones de este tipo de alimentos o componentes alimentarios.


Assuntos
Humanos , Saúde , Suplementos Nutricionais , Alimento Funcional , Dieta Saudável
20.
Biosci. j. (Online) ; 30(2): 556-564, mar./apr. 2014. ilus, tab
Artigo em Português | LILACS | ID: biblio-947168

RESUMO

Existem variedades de mandioca que apresentam compostos como os carotenoides, beta-caroteno, licopeno e minerais importantes para a saúde humana e animal. O presente estudo avaliou a atividade antioxidante das variedades branca, amarela e rosada de Manihot esculenta, por meio de teste de DPPH e pela atividade quelante de íons ferro. Além disso, o conteúdo de fenóis totais, carotenoides, beta-caroteno, licopeno e zinco também foram determinados. Utilizando o teste de DPPH foi possível verificar que os extratos de amostras cozidas apresentaram maior atividade antioxidante (89,53% - rosada) em comparação com as amostras frescas (1,97% - branca). Para o teste de atividade quelante de íons ferro, a maior atividade foi encontrada para o extrato da variedade rosada cozida (63,43%) e a menor foi do extrato da amarela in natura (17,34%) a amostra branca não apresentou atividade. A maior concentração de fenóis e de zinco foi obtida para o extrato da variedade rosada cozida 136,12 mg EAG/g de extrato e 0,811 ppm, respectivamente, na concentração de 1000 µg/mL. A variedade rosada apresentou também maior quantidade de pigmentos, incluindo carotenoides (29,40 µg/g); beta-caroteno (9,14 µg/100g) e licopeno (68,92%). De acordo com os resultados obtidos no presente estudo, foi possível concluir que as variedades amarela e rosada de M. esculenta, apresentam quantidades de compostos fenólicos e minerais suficientes para atribuir a atividade antioxidante, podendo assim, contribuir para diminuir os danos oxidativos e serem utilizadas como nutracêuticos ou diretamente ingeridas na dieta para manter a boa saúde.


There are cassava varieties that present compounds as carotenoids, beta-carotene, lycopene and minerals important for human and animal health. The present study evaluated the antioxidant activity of the white, yellow and pinkish varieties of Manihot esculenta, by mean of the DPPH test and by the ferrous ion-chelating activity. Furthermore, the total phenols, carotenoids, beta-carotene, lycopene and zinc contents were also determined. Utilizing the DPPH test it was possible to find that extracts of boiled samples presented higher antioxidant activity (89.53% - pinkish) in comparison to the fresh samples (1.97% - white). For the ferrous ion-chelating test, the highest activity was found for the boiled pinkish variety extract (63.43%) and the lowest was for fresh yellow extract (17.34%) the white sample did not present activity. The highest concentration of total phenols and zinc content was obtained for the boiled pinkish variety extract 136.12 mg EAG/g of extract and 0,811ppm, respectively, in the concentration of 1000 µg/mL. The pinkish variety presented also higher quantity of pigments, including carotenoid (29.40 µg/g), beta-carotene (9.14 µg/100g) and lycopene (68.92%). According to the results obtained in this study it was possible to conclude that the yellow and pinkish varieties of M. esculenta present quantity of phenolic compounds and minerals sufficient to attribute the antioxidant activity and may thus contribute to reduce oxidative damage and be used as nutraceuticals or directly ingested in the diet to maintain good health.


Assuntos
Zinco , Carotenoides , Manihot , beta Caroteno , Suplementos Nutricionais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...